Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

TechCrunch - Sep 23, 2026

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read full article

More News

Kick Connect
About Us

Kick Connect publishes a comprehensive overview of the latest news and theories on science & technology. We also report accurate news with a unique perspective on the world around us.